The pain-relieving apparatus has a housing, a stimulating surface, user inputs, and a plurality of ports, such as a battery port and a transcutaneous electrical nerve stimulation (TENS) output connector. The stimulating surface may include a suction ring, vacuum apertures, vibration stimulators, a plate, heat and cold transducer elements, and medicinal holders to provide various approaches for relieving pain. The pain-relieving apparatus may also have a sound speaker for producing nerve stimulating sounds.

A massage machine includes a casing unit, a drive device, a transmission mechanism, and two massage plate units. Two ends of the transmission mechanism are linked with the massage plate units, respectively. The drive device drives the transmission mechanism. The transmission mechanism and the drive device are disposed in the casing unit. The massage plate units are disposed on the casing unit. The massage machine uses a single drive device to drive the transmission mechanism, so that the transmission mechanism can link the two massage plate units to massage a user.

Disclosed is a massage beauty instrument, which includes a main body. The main body includes a host and a beauty massage head connected to the host. The beauty massage head is provided with a vibration portion therein. The vibration portion includes a driving motor fixed in the beauty massage head, a first eccentric wheel and a second eccentric wheel connected in series to both ends of an output shaft of the driving motor, respectively.

The current invention includes a therapeutic medical device, specifically, a modular myofascial release device configured to perform directed, or self-directed myofascial release, deep tissue massage, or joint mobilization as a single or modular unit on a subject in need thereof.

A system and method for direct connect tissue fascia with a thin filiform needle piercing the skin, going underneath the skin into connective tissue fascia layer, to directly manipulate (stretch and vibrate) connective tissue fascia to reduce fascia adhesion/restriction and achieve efficient fascia release outcome.

A cold plasma system and method for treating a region of a biological surface is presented. In one embodiment, the system includes: a housing; an air conduit within the housing; a first electrode configured proximately along the air conduit; a second electrode configured proximately along the air conduit and opposite from the first electrode; and a source of alternating current (AC) electrically connected with the first electrode. The source of alternating current is configured to generate cold plasma in the air conduit.

A system is disclosed. The system has an accessory control module, comprising computer-executable code stored in non-volatile memory, a processor, a user device of a human viewer, a viewer accessory configured to communicate with the user device, the viewer accessory including a first motor or a first heater, a model device of a human model, and a model accessory configured to communicate with the model device, the model accessory including a second motor or a second heater. The accessory control module, the processor, the user device, the viewer accessory, the model device, and the model accessory are configured to provide a chat communication application between the human viewer and the human model configured to provide chat between the human viewer via the user device and the human model via the model device.

A gastrointestinal treatment system including a gastrointestinal capsule adapted to treat a subject following ingestion of the gastrointestinal capsule. The gastrointestinal capsule includes: (a) a housing; (b) a vibrating agitator, powered by the battery, the vibrating agitator adapted such that, in a first vibrating mode of operation, the housing exerts vibrations on an environment surrounding the capsule; (c) a power supply disposed within the housing and adapted to power the vibrating agitator; and (d) a controller adapted, in response to receipt of an activation input, to activate the vibrating agitator to operate in the first vibrating mode of operation at at least one predetermined time of day. The system and method may be used to treat an ailment of the gastrointestinal tract and/or to mitigate at least one symptom of jetlag in a subject travelling from an origin location to a destination location.

A gastrointestinal treatment system including a gastrointestinal capsule adapted to treat a subject following ingestion of the gastrointestinal capsule. The gastrointestinal capsule includes: (a) a housing; (b) a vibrating agitator, powered by the battery, the vibrating agitator adapted such that, in a first vibrating mode of operation, the housing exerts vibrations on an environment surrounding the capsule; (c) a power supply disposed within the housing and adapted to power the vibrating agitator; and (d) a controller adapted, in response to receipt of an activation input, to activate the vibrating agitator to operate in the first vibrating mode of operation at at least one predetermined time of day. The system and method may be used to treat an ailment of the gastrointestinal tract and/or to mitigate at least one symptom of jetlag in a subject travelling from an origin location to a destination location.

A system and method of monitoring, controlling and/or detecting events during the removal of heat from subcutaneous lipid-rich tissue is described. In some examples, the system detects an increase in temperature at a treatment device in contact with the skin of a subject, determines that the increase in temperature is related to a treatment event, and performs an action based on the determination. In some examples, the system shuts off the treatment device, alerts an operator, or reduces the cooling in response to a determined treatment event.